|1.||Villalón, Carlos M: 2 articles (10/2007 - 03/2002)|
|2.||Centurión, David: 2 articles (10/2007 - 03/2002)|
|3.||Heinemann, Uwe: 1 article (12/2012)|
|4.||Fano, Silvia: 1 article (12/2012)|
|5.||Çalışkan, Gürsel: 1 article (12/2012)|
|6.||Kauer-Sant'Anna, Marcia: 1 article (01/2010)|
|7.||Imperial, Miguel: 1 article (01/2010)|
|8.||Ruth, Thomas J: 1 article (01/2010)|
|9.||Sossi, Vesna: 1 article (01/2010)|
|10.||Erez, Jonathan: 1 article (01/2010)|
|1.||Schizophrenia (Dementia Praecox)
01/01/1999 - "Several postmortem studies have reported a decreased density of serotonin 5-HT2 receptors in the prefrontal cortex in schizophrenia. "
07/01/1993 - "Platelet serotonin-2 receptors in schizophrenia: effects of illness and neuroleptic treatment."
01/01/1999 - "Serotonin 5-HT2 receptors in schizophrenia: a PET study using [18F]setoperone in neuroleptic-naive patients and normal subjects."
11/01/2002 - "Apart from their differential propensities to block dopamine D2 and serotonin 5-HT2 receptors, the molecular mechanisms underlying the clinical efficacy of typical and atypical antipsychotics in schizophrenia are largely unknown. "
01/01/1996 - "The findings indicate that loxapine displays an extremely strong binding affinity for dopamine D4 and serotonin 5-HT2 receptors, which suggests that both serotonergic and dopaminergic mechanisms contribute to the antipsychotic drug action and EPS associated with loxapine in the treatment of schizophrenia."
|2.||Migraine Disorders (Migraine)
05/01/1990 - "Serotonin S2 receptors and migraine: a study with the selective antagonist ICI 169,369."
11/01/1992 - "By using [3H]-spiperone as a radioligand and ketanserin to determine the non-specific binding, the numbers of 5-HT2 serotonin receptors on platelet membrane obtained from normal healthy and migraine subjects were determined. "
12/01/1991 - "Serotonergic mechanisms have recently been implicated in the pathogenesis of portal hypertension; this suggests that blockade of serotonin S2 receptors may be a new approach for the pharmacological therapy of portal hypertension. "
05/01/1988 - "These results seem to indicate that the activation of serotonin S2 receptors may play a role in determining the portal hypertension in cirrhotic patients."
|4.||Hypertension (High Blood Pressure)
11/01/1989 - "The influence of blockade of serotonin S2 receptors with ketanserin was studied in two strains of rats with inherited arterial hypertension: spontaneously hypertensive rats (SHR strain) and rats with inherited stress-induced arterial hypertension (ISIAH strain). "
10/01/2007 - "Furthermore, central administration of 5-HT can cause both hypotension (mainly mediated by 5-HT(1A) receptors) and hypertension (mainly mediated by 5-HT(2) receptors). "
|5.||Mood Disorders (Mood Disorder)
|2.||Antipsychotic Agents (Antipsychotics)
|4.||Serotonin (5 Hydroxytryptamine)
|9.||Histamine Receptors (Histamine Receptor)
|10.||Dopamine Receptors (Dopamine Receptor)